Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / supernus stock slides as fda rejects parkinson s dis

SUPN - Supernus stock slides as FDA rejects Parkinson's disease infusion device

Supernus Pharmaceuticals Inc.

2024-04-08 08:39:34 ET

Supernus Pharmaceuticals ( NASDAQ: SUPN ) shares dipped ~11% premarket on Monday after the U.S. drug regulator rejected its experimental apomorphine infusion device for the continuous treatment of motor fluctuations associated with Parkinson’s disease....

For further details see:

Supernus stock slides as FDA rejects Parkinson's disease infusion device
Stock Information
Company Name: Supernus Pharmaceuticals Inc.
Stock Symbol: SUPN
Market: NASDAQ
Website: supernus.com
Menu
SUPN SUPN Quote SUPN Short SUPN News SUPN Articles SUPN Message Board
Get SUPN Alerts

News, Short Squeeze, Breakout and More Instantly...